Bardoxolone-Methyl (CDDO-Me) Impairs Tumor Growth and Induces Radiosensitization of Oral Squamous Cell Carcinoma Cells

Radiotherapy represents a common treatment strategy for patients suffering from oral squamous cell carcinoma (OSCC). However, application of radiotherapy is immanently limited by radio-sensitivity of normal tissue surrounding the tumor sites. In this study, we used normal human epithelial keratinocy...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Cornelius Hermann, Simon Lang, Tanja Popp, Susanne Hafner, Dirk Steinritz, Alexis Rump, Matthias Port, Stefan Eder
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2021-01-01
Saila:	Frontiers in Pharmacology
Gaiak:	oral squamous cell carcinoma radiotherapy reactive oxygen species heme oxygenase-1 bardoxolone-methyl
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fphar.2020.607580/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!